CadreAI: Agentic AI for Semantically Decoupled Protein–Drug Design and Optimization

Abstract De novo drug design must balance global drug properties with local structural determinants of target specificity. However, existing methods often reduce both objectives to local geometric optimization, relying on blind, reward-driven perturbations that can disrupt essential scaffolds and compromise overall drug-likeness. To resolve this destructive optimization trap, we propose CadreAI, a semantically decoupled agentic de novo drug design framework. CadreAI explicitly decomposes the entire drug design process into two independent subtasks: target-oriented semantic planning and plan-conditioned molecular generation. This strict separation mitigates potential task interference, allowing each module to focus exclusively on its dedicated objective without mutual disruption. Crucially, the strategic logic of how to formulate these target-oriented plans is driven by Simulation-Guided Insight Consolidation (SGIC). To eliminate trial-and-error guessing, this persistent memory mechanism translates transient numerical docking feedback into reusable textual heuristics, allowing the agent to continuously learn and logically deduce subsequent structural edits. Evaluated on the CrossDocked2020 and DrugGen benchmarks, molecules generated by CadreAI achieve superior docking performance with suitable drug-likeness and synthetic accessibility. Additional Boltz-2 evaluations provide orthogonal computational validation of predicted structural plausibility and binding affinity. These results demonstrate that semantically decoupled reasoning offers a highly controllable and practical route for in silico therapeutic design.

Authors

Institutions

Publication Details

Journal
Journal of Chemical Information and Modeling
Published
2026-11-13
DOI
https://doi.org/10.1021/acs.jcim.6c02788
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

CadreAI: Agentic AI for Semantically Decoupled Protein–Drug Design and Optimization

Pong Chi Yuen, Fei Lyu, Feng Pan
1 links
Journal of Chemical Information and Modeling
Computational Drug Discovery Methods
article

CadreAI: Agentic AI for Semantically Decoupled Protein–Drug Design and Optimization

Pong Chi Yuen, Fei Lyu, Feng Pan
article en

Abstract

Abstract De novo drug design must balance global drug properties with local structural determinants of target specificity. However, existing methods often reduce both objectives to local geometric optimization, relying on blind, reward-driven perturbations that can disrupt essential scaffolds and compromise overall drug-likeness. To resolve this destructive optimization trap, we propose CadreAI, a semantically decoupled agentic de novo drug design framework. CadreAI explicitly decomposes the entire drug design process into two independent subtasks: target-oriented semantic planning and plan-conditioned molecular generation. This strict separation mitigates potential task interference, allowing each module to focus exclusively on its dedicated objective without mutual disruption. Crucially, the strategic logic of how to formulate these target-oriented plans is driven by Simulation-Guided Insight Consolidation (SGIC). To eliminate trial-and-error guessing, this persistent memory mechanism translates transient numerical docking feedback into reusable textual heuristics, allowing the agent to continuously learn and logically deduce subsequent structural edits. Evaluated on the CrossDocked2020 and DrugGen benchmarks, molecules generated by CadreAI achieve superior docking performance with suitable drug-likeness and synthetic accessibility. Additional Boltz-2 evaluations provide orthogonal computational validation of predicted structural plausibility and binding affinity. These results demonstrate that semantically decoupled reasoning offers a highly controllable and practical route for in silico therapeutic design.

Journal of Chemical Information and Modeling
Hong Kong Baptist University (HK), Wuhan University of Technology (CN)
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon